ANDA 70377, held by Watson Labs. Amitriptyline Hydrochloride; Perphenazine.
As of Nov 15, 2026, ANDA 70377 (Perphenazine And Amitriptyline Hydrochloride), held by Watson Labs, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Perphenazine And Amitriptyline Hydrochloride50MG;4MG ยท tablet;oral | Amitriptyline Hydrochloride; Perphenazine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
